Jefferies Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $20M | Buy |
171,119
+171,006
| +151,333% | +$21.2M | 0.17% | 96 |
|
|
2022
Q2 | $13.3K | Sell |
113
-247,000
| -100% | -$29.3M | ﹤0.01% | 1459 |
|
|
2022
Q1 | $32.2M | Buy |
247,113
+247,000
| +218,584% | +$32.2M | 0.2% | 78 |
|
|
2021
Q4 | $17.2K | Sell |
113
-70,710
| -100% | -$10.9M | ﹤0.01% | 1566 |
|
|
2021
Q3 | $11.5M | Sell |
70,823
-40,300
| -36% | -$6.78M | 0.08% | 223 |
|
|
2021
Q2 | $18.2M | Buy |
111,123
+93,641
| +536% | +$14.4M | 0.11% | 143 |
|
|
2021
Q1 | $2.63M | Sell |
17,482
-12,371
| -41% | -$1.96M | 0.02% | 585 |
|
|
2020
Q4 | $4.52M | Buy |
29,853
+12,000
| +67% | +$1.71M | 0.04% | 444 |
|
|
2020
Q3 | $2.42M | Sell |
17,853
-519,309
| -97% | -$70.5M | 0.03% | 502 |
|
|
2020
Q2 | $73.4K | Buy |
537,162
+233,779
| +77% | +$29.8M | 0.87% | 15 |
|
|
2020
Q1 | $32.7M | Buy |
303,383
+167,043
| +123% | +$19.2M | 0.36% | 30 |
|
|
2019
Q4 | $16.4M | Sell |
136,340
-9,768
| -7% | -$1.09M | 0.13% | 140 |
|
|
2019
Q3 | $14.5M | Buy |
146,108
+86,795
| +146% | +$9.09M | 0.11% | 125 |
|
|
2019
Q2 | $6.47M | Buy |
59,313
+50,010
| +538% | +$5.32M | 0.05% | 367 |
|
|
2019
Q1 | $1.04M | Sell |
9,303
-71,632
| -89% | -$7.86M | 0.01% | 1253 |
|
|
2018
Q4 | $7.8M | Buy |
80,935
+76,642
| +1,785% | +$8.13M | 0.06% | 252 |
|
|
2018
Q3 | $523K | Sell |
4,293
-1,000
| -19% | -$118K | ﹤0.01% | 1617 |
|
|
2018
Q2 | $581K | Sell |
5,293
-357,500
| -99% | -$38.2M | ﹤0.01% | 1516 |
|
|
2018
Q1 | $38.7M | Buy |
362,793
+346,000
| +2,060% | +$38.4M | 0.21% | 54 |
|
|
2017
Q4 | $1.79M | Buy |
16,793
+13,073
| +351% | +$1.4M | 0.01% | 1048 |
|
|
2017
Q3 | $414K | Hold |
3,720
| – | – | ﹤0.01% | 1730 |
|
|
2017
Q2 | $384K | Buy |
3,720
+495
| +15% | +$48.8K | ﹤0.01% | 1735 |
|
|
2017
Q1 | $315K | Buy |
3,225
+1,743
| +118% | +$167K | ﹤0.01% | 1805 |
|
|
2016
Q4 | $131K | Sell |
1,482
-34,218
| -96% | -$3.11M | ﹤0.01% | 1981 |
|
|
2016
Q3 | $3.44M | Buy |
+35,700
| New | +$3.4M | 0.02% | 685 |
|
|
2016
Q2 | – | Sell |
-22,491
| Closed | -$1.96M | – | 2267 |
|
|
2016
Q1 | $1.96M | Buy |
22,491
+17,091
| +317% | +$1.53M | 0.01% | 853 |
|
|
2015
Q4 | $609K | Sell |
5,400
-26,400
| -83% | -$2.87M | ﹤0.01% | 1419 |
|
|
2015
Q3 | $3.21M | Buy |
+31,800
| New | +$3.81M | 0.02% | 681 |
|
|
2014
Q4 | – | Sell |
-300
| Closed | -$29.2K | – | 2119 |
|
|
2014
Q3 | $27K | Hold |
300
| – | – | ﹤0.01% | 2019 |
|
|
2014
Q2 | $26K | Buy |
+300
| New | +$23.6K | ﹤0.01% | 1965 |
|
Other funds holding IBB
CB
Jefferies Group's IBB Position: Q3 2022 in Review
Jefferies Group increased its iShares Biotechnology ETF (IBB) stake by 151,333% in Q3 2022, buying an estimated $21.2M and bringing the position to 171,119 shares worth $20M. The position accounts for 0.17% of the portfolio, ranked #96.
Jefferies Group first reported a position in IBB in Q2 2014 and has held it in 30 quarters since. The position peaked at $38.7M in Q1 2018. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.
- Jefferies Group held 171,119 shares of iShares Biotechnology ETF worth $20M as of Q3 2022.
- Jefferies Group bought 171,006 iShares Biotechnology ETF shares in Q3 2022, an estimated $21.2M.
- iShares Biotechnology ETF made up 0.17% of Jefferies Group's portfolio in Q3 2022, its #96 holding.
- Jefferies Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 30 quarters since.
- Jefferies Group's iShares Biotechnology ETF position peaked at $38.7M in Q1 2018.
- 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.